Sonic Healthcare Ltd (SKHCF) Q4 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Sonic Healthcare FY2026 full year results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Dr. Jim Newcombe, Chief Executive Officer and Managing Director of Sonic Healthcare. Sir, please go ahead. Good morning, everyone. Thank you for joining Sonic Healthcare's FY2026 full-year results presentation. On the call with me today are Sonic Healthcare's Chief Financial Officer, Chris Wilks, and Deputy Chief Financial Officer, Paul Alexander. We delivered solid financial results in FY2026, achieving our EBITDA guidance for the year on an underlying basis. Total revenue grew strongly, up 13% year on year to $10.867 billion, with strong EBITDA growth of 11% to $1.933 billion. Net profit after tax increased 17% to $621 million, with earnings per share up by 14% to $1.26. Operationally, we completed the acquisition of the LADR Group in Germany, further strengthening our position in that market, with synergy realisation well on track. In Switzerland, we continued substantial synergy capture from our recent acquisitions, which are also well on schedule. Across Sonic's portfolio, we achieved strong growth in advanced diagnostics, leveraging market-leading brands across multiple geographies, including our acquisition in the US this year of Cairo Diagnostics. We commenced an operating r...